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Abstract The e¡ects of isoproterenol on sialidase activity in
rat cardiomyocytes were examined. Administration of isoproter-
enol to rats (0.2 or 2 mg/kg body weight) produced an increase
in sialidase activity in total membrane fraction of heart tissue
within 120 min (121# 13% of the control at 120 min after
administration of 0.2 mg isoproterenol/kg, n=5, P6 0.05). Sia-
lidase activity in cardiomyocyte-derived H9c2 cells was also
increased by treatment with isoproterenol (10 WM) for 60 min.
The e¡ect of isoproterenol on sialidase activity was ampli¢ed by
the addition of 3-isobutyl-1-methylxanthine (IBMX). Sialidase
activity in H9c2 cells was elevated by treatment with dibutyryl
cAMP plus IBMX without isoproterenol. The content of
N-acetylneuraminic acid in cells decreased by 22% after treat-
ment with isoproterenol plus IBMX. These results suggest that
sialidase activity in rat cardiomyocytes is regulated by L-adren-
ergic stimulators via a cAMP-dependent process. The increased
activity of sialidase may account for the reduction of sialic acid
content of cells.
3 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Sialidase is an exoglycosidase that cleaves K-linked sialic
acid residues of sialoglycoconjugates [1]. This enzyme plays
a crucial role in the catabolism of sialoglycoconjugates; the
de¢ciency of sialidase activity in sialidosis or galactosialidosis
causes accumulation of sialooligosaccharides, sialoglycopro-
teins, and gangliosides in tissues [2]. Sialidase has also been
implicated in diverse cellular events including development [3^
6], growth and di¡erentiation [7^10], aging [11,12], and neo-
plastic transformation [13]. While sialidase activity undergoes
speci¢c changes during these biological processes, the regula-
tory mechanism of enzyme activity remains to be clari¢ed.
Previously, it was reported that intravenous administration
of L-adrenergic agonists to mice causes a signi¢cant decrease
in sialic acid contents of parotid plasma membranes [14^17].
These ¢ndings led us to the assumption that L-adrenergic
stimulation may cause an increase in sialidase activity, which
accelerates the degradation of sialic acid compounds in cells.
In the present study, we examined the e¡ects of isoproterenol
on sialidase activity in rat heart tissue and clonal cardiomyo-
cyte-derived H9c2 cells in culture. We also investigated the
in£uence of L-adrenergic stimulation on sialic acid contents
of H9c2 cells.
2. Materials and methods
2.1. Materials
Seven-week-old Sprague^Dawley male rats were purchased from
Japan SLC (Shizuoka, Japan). Rat cardiomyocyte-derived H9c2 cells
were obtained from American Type Culture Collection (Manassas,
VA, USA). Other reagents were purchased from the following com-
panies: L-(3)-isoproterenol (ICN Biomedicals, Aurora, OH, USA),
1,2-diamino-4,5-methylenedioxybenzene (DMB, Dojindo Laborato-
ries, Kumamoto, Japan), and 3-isobutyl-1-methylxanthine (IBMX)
and 4-methylumbelliferyl-N-acetylneuraminic acid (4MU-Neu5Ac)
(Sigma, St. Louis, MO, USA).
2.2. Administration of isoproterenol to animals
Isoproterenol was administered to rats as an intravenous bolus
(0.02^2 mg/kg body weight) through the tail vein. At 20 or 120 min
after isoproterenol administration, the animals were decapitated, and
the heart tissues were excised. Subcellular fractionation of heart tissue
was performed at 4‡C. Tissue was homogenized with 8 volumes of
0.32 M sucrose containing 25 mM KCl, 3 mM MgCl2, 2 mM CaCl2
and 50 mM Tris^HCl (pH 7.4) using a Te£on-glass homogenizer. The
homogenate was centrifuged at 650Ug for 10 min. The pellet was
homogenized with the same volume of bu¡er and centrifuged under
the same condition. The supernatants were combined and centrifuged
at 100 000Ug for 30 min. The resultant pellet was used as total mem-
brane fraction.
2.3. Cell culture
Clonal H9c2 cells were grown in Dulbecco’s modi¢ed Eagle’s me-
dium (DMEM) supplemented with 10% fetal bovine serum under 5%
CO2 in air at 37‡C [18]. For experiments, cells at 80^90% con£uence
were preincubated in serum-free DMEM at 37‡C for 10 min, followed
by treatment with 1 or 10 WM isoproterenol for 60 min under the
serum-free condition. In some experiments, cells were treated with 100
WM IBMX for 30 min after a 10 min preincubation period, followed
by treatment with the L-adrenergic agonist in the presence of IBMX.
The treated cells were washed twice with cold phosphate-bu¡ered sa-
line (pH 7.4), scraped o¡ the dish, and homogenized in 10 mM Tris^
HCl, pH 7.4 using a Te£on-glass homogenizer.
2.4. Sialidase assay
Sialidase activity was measured using 4MU-Neu5Ac as the sub-
strate [19]. The reaction mixture consisted of 0.2 mM 4MU-Neu5Ac,
0.1 M sodium acetate bu¡er (pH 4.8), and enzyme preparation (40^
200 Wg as protein) in a ¢nal volume of 100 Wl. After incubation at
37‡C for 1 h, the reaction was terminated by addition of 0.15 M
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glycine^NaOH bu¡er (pH 10.8, 2.9 ml). The released 4MU was quan-
titated by measuring £uorescence at excitation and emission wave-
lengths of 365 nm and 445 nm, respectively [20]. Preliminary experi-
ments showed that this assay condition was optimal for measuring
sialidase activity in rat heart tissue and H9c2 cells (data not shown).
Protein was determined by the method of Lowry et al. [21].
2.5. Sialic acid analysis
Sialic acids in H9c2 cells were quantitated using a £uorometric high
performance liquid chromatographic (HPLC) method [22] with
N-propanoylneuraminic acid (Neu5Prop) as an internal standard
[23]. In brief, an aliquot of cell homogenate was treated in 50 mM
sulfuric acid at 80‡C for 1 h. A ¢xed amount of Neu5Prop was added
to the hydrolysate, followed by incubation of the mixture with DMB
reagent at 60‡C for 2.5 h. The £uorescent derivatives of sialic acids
were analyzed by HPLC equipped with an ODS column (Mightysil
RP 18, 250U4.6 mm, Kanto Chemicals, Tokyo, Japan) and £uores-
cence detector. The excitation and emission wavelengths were 373 and
448 nm, respectively.
3. Results
Three di¡erent doses of isoproterenol were administered to
rats, and sialidase activity in total membrane fractions of
heart tissue was examined. At the lowest dose (i.e. 0.02 mg
isoproterenol/kg body weight), sialidase activity tended to in-
crease, but did not reach a statistically signi¢cant level at 120
min after isoproterenol administration. At the middle dose
(0.2 mg/kg), sialidase activity increased and reached a 1.21-
fold level of control at 120 min (Fig. 1A). The time required
for the response of sialidase activity was shortened to 20 min
using the highest dose of isoproterenol (i.e. 2 mg/kg) (Fig.
1B).
The e¡ect of isoproterenol on sialidase activity was further
examined using a clonal H9c2 cell line. Sialidase activity in-
creased at 1 WM of isoproterenol, though statistical signi¢-
cance was not attained by incubation for 60 min. The enzyme
activity signi¢cantly increased at 10 WM isoproterenol (Fig. 2).
The response of sialidase activity to isoproterenol was magni-
¢ed in the presence of IBMX (100 WM), a phosphodiesterase
inhibitor (Fig. 3). Sialidase activity in H9c2 cells was also
elevated by treatment with dibutyryl cAMP (1 mM) plus
IBMX (100 WM) in the absence of L-agonist (Fig. 4).
Sialic acid analysis was performed using H9c2 cells treated
with isoproterenol plus IBMX (Table 1). The Neu5Ac content
was reduced to 78% of the control. No signi¢cant di¡erence in
the content of Neu5Gc was observed between the treated cells
and control.
Fig. 1. E¡ect of isoproterenol on sialidase activity in total membrane fractions of rat heart tissue. Seven-week-old rats were intravenously ad-
ministered a single dose of isoproterenol (0.02^2 mg/kg body weight). The heart tissue was excised at 120 min (A) or 20 min (B) after adminis-
tration of isoproterenol. Sialidase activity in total membrane fraction was assayed at pH 4.8 using 4MU-Neu5Ac. Each column and attached
bar represent the meanQS.D. (n=5 for each group). Statistical analysis was performed by Student’s t-test. *P6 0.05.
Fig. 2. E¡ect of isoproterenol on sialidase activity in H9c2 cells.
Rat cardiomyocyte-derived H9c2 cells in culture were preincubated
in serum-free DMEM at 37‡C for 10 min, followed by treatment
with 1 or 10 WM isoproterenol for 60 min. Cells were homogenized
in 10 mM Tris^HCl, pH 7.4 and subjected to sialidase assay as de-
scribed in Fig. 1. Each column and attached bar represent the
meanQS.D. (n=4 for each group). *P6 0.05.
Fig. 3. E¡ect of IBMX on the isoproterenol-induced increase of sia-
lidase activity in H9c2 cells. Rat cardiomyocyte-derived H9c2 cells
in culture were preincubated in serum-free DMEM at 37‡C for 10
min, followed by incubation with 100 WM IBMX. The cells were
then treated with 10 WM isoproterenol for 60 min without changing
the medium. Each column and attached bar represent the
meanQS.D. (n=4 for each group). **P6 0.01.
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4. Discussion
There are several studies reporting changes of sialidase ac-
tivity caused by exogenously added chemical agents to cells.
For example, retinoic acid or lipopolysaccharides have been
shown to increase sialidase activity in human leukemia HL-60
cells [24] or mouse T lymphocytes [25]. However, the re-
sponses of sialidase activity were relatively slow and required
days to be seen. Thus, it is assumed that the observed changes
may not be a direct outcome caused by the agents, but rep-
resent one of many complex di¡erentiation processes in cells.
In the present study, we examined the e¡ects of the L-adren-
ergic agonist isoproterenol on sialidase activity in rat heart
tissue and the clonal H9c2 cell line. H9c2 cells were originally
established from embryonic rat ventricle and have been shown
to preserve elements of electrical and hormonal signaling
pathways found in adult cardiomyocytes [26,27]. The expres-
sion of L1- and L2-adrenergic receptors in functional states has
also been demonstrated [28]. Isoproterenol was shown to pro-
duce a rapid increase in sialidase activity of rat cardio-
myocytes under in vitro and in vivo experimental conditions
within 1 h. This is the ¢rst report about pharmacological
regulation of sialidase activity.
The increased sialidase activity in isoproterenol-treated
H9c2 cells was strongly augmented by co-treatment of cells
with IBMX, a phosphodiesterase inhibitor. It is known that
L-adrenergic agonists raise the intracellular cAMP levels of
target cells. This e¡ect is ampli¢ed by treatment with IBMX
[29]. It was thus suggested that the elevation of intracellular
cAMP may be responsible for the increase in sialidase activity.
This assumption was supported by the observation that the
treatment of H9c2 cells with dibutyryl cAMP plus IBMX
generated a similar e¡ect on sialidase activity as that of iso-
proterenol.
Isoproterenol not only produced an increase in sialidase
activity, but also brought a concomitant reduction of sialic
acid contents in cells. It is known that most sialic acids are
associated with plasma membranes in eukaryotic cells [30].
Evidence has also been provided suggesting the signi¢cance
of plasma membrane-bound sialidase in the catabolism of
sialoglycoconjugates in the membranes. For example, plasma
membrane-bound sialidase may play an important role in the
turnover of gangliosides in brain myelin [31] or neuroblasto-
ma cells [32]. A positive correlation between the activity of
plasma membrane sialidase and the turnover rate of radio-
labeled sialic acid compounds on the cell surface was observed
with Rous sarcoma virus-transformed chick embryonic ¢bro-
blasts [33]. It is thus reasonable to speculate that the increased
activity of membrane-bound sialidase by L-agonists may ac-
count for the reduction of sialic acid contents in H9c2 cells.
To clarify this issue, identi¢cation of sialidase isoenzymes re-
sponding to L-adrenergic stimulation would be required in a
future study.
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